Maturity-Onset Diabetes of the Young and Hepatic Adenomatosis – Characterisation of a New Mutation

Abstract

Aim:

Hepatocyte nuclear factor 1 alpha (HNF1A) mutations cause maturity-onset diabetes of the young (MODY) type 3. Further extending the phenotypic spectrum, HNF1A mutations are associated with hepatic adenomatosis. A 20-year old lean, female patient with newly diagnosed diabetes mellitus was negative for diabetes-associated autoantibodies and had no relevant family history. Hepatic adenomatosis was diagnosed. Her HNF1A gene was examined and identified alterations further analysed.

Methods & Results:

Sequencing of her HNF1A gene revealed a previously uncharacterised Q495X nonsense mutation, along with the known A98V polymorphism, both in the heterozygous state. The patient’s father was also a carrier of both the mutation and the polymorphism. An oral glucose tolerance test (OGTT) revealed impaired glucose tolerance, whereas imaging of his liver was unremarkable. Wild type HNF1A and HNF1A carrying the Q495X mutation were co-transfected in reporter gene assays. The mutation causes a dominant-negative HNF1A protein variant which blocks HNF1A wild-type-mediated gene expression.

Conclusion:

The novel Q495X mutation is the likely cause of our patient’s diabetes and hepatic adenomatosis. It may also cause her father’s impaired glucose tolerance. More generally speaking, if non-autoimmune diabetes is suspected, examination of the liver may provide important diagnostic clues. Furthermore, patients with hepatic adenomatosis without known diabetes should be screened by OGTT. Relatives of patients with HNF1A mutations should also be screened by OGTT to detect potential early-stage diabetes.

Key words

MODY3 - HNF1A - hepatic adenomatosis

• References

• 1 Steck AK, Winter WE. Review on monogenic diabetes. Curr Opin Endocrinol Diabetes Obes 2011; 18: 252-258
• 2 O’Neill MJF. Maturity-onset diabetes of the young In: Online Mendelian Inheritance in Man, http://omimorg/entry/606391 accessed 2/28/2013: Johns Hopkins University
• 3 Vaxillaire M, Froguel P. Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. Endocr Rev 2008; 29: 254-264
• 4 Awa WL, Thon A, Raile K et al. Genetic and clinical characteristics of patients with HNF1A gene variations from the German-Austrian DPV database. Eur J Endocrinol 2011; 164: 513-520
• 5 Fajans SS, Bell GI. Phenotypic heterogeneity between different mutations of MODY subtypes and within MODY pedigrees. Diabetologia 2006; 49: 1106-1108
• 6 Bellanne-Chantelot C, Levy DJ, Carette C et al. Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene. J Clin Endocrinol Metab 2011; 96: E1346-E1351
• 7 Bluteau O, Jeannot E, Bioulac-Sage P et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002; 32: 312-315
• 8 Bacq Y, Jacquemin E, Balabaud C et al. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology 2003; 125: 1470-1475
• 9 Jeannot E, Lacape G, Gin H et al. Double heterozygous germline HNF1A mutations in a patient with liver adenomatosis. Diabetes Care 2012; 35: e35
• 10 Reznik Y, Dao T, Coutant R et al. Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab 2004; 89: 1476-1480
• 11 Zucman-Rossi J, Jeannot E, Nhieu JT et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006; 43: 515-524
• 12 Nishikawa T, Hagihara K, Serada S et al. Transcriptional complex formation of c-Fos, STAT3, and hepatocyte NF-1 alpha is essential for cytokine-driven C-reactive protein gene expression. J Immunol 2008; 180: 3492-3501
• 13 Rajkovic M, Iwen KA, Hofmann PJ et al. Functional cooperation between CREM and GCNF directs gene expression in haploid male germ cells. Nucleic Acids Res 2010; 38: 2268-2278
• 14 Holmkvist J, Cervin C, Lyssenko V et al. Common variants in HNF-1 alpha and risk of type 2 diabetes. Diabetologia 2006; 49: 2882-2891
• 15 Urhammer SA, Hansen T, Ekstrom CT et al. The Ala/Val98 polymorphism of the hepatocyte nuclear factor-1alpha gene contributes to the interindividual variation in serum C-peptide response during an oral glucose tolerance test: evidence from studies of 231 glucose-tolerant first degree relatives of type 2 diabetic probands. J Clin Endocrinol Metab 1998; 83: 4506-4509
• 16 Urhammer SA, Rasmussen SK, Kaisaki PJ et al. Genetic variation in the hepatocyte nuclear factor-1 alpha gene in Danish Caucasians with late-onset NIDDM. Diabetologia 1997; 40: 473-475
• 17 Bergmann A, Li J, Selisko T et al. The A98V single nucleotide polymorphism (SNP) in hepatic nuclear factor 1 alpha (HNF-1alpha) is associated with insulin sensitivity and beta-cell function. Exp Clin Endocrinol Diabetes 2008; 116: S50-S55
• 18 Jeannot E, Poussin K, Chiche L et al. Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma. Cancer Res 2007; 67: 2611-2616